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ABSTRACT. 
 
The main aim for this study is to provide clear picture regarding the outcome of  tongue 
cancer patients treated in University Malaya Medical Centre. This centre can be 
addressed as a Centre of Referral for Malaysia generally. Tongue cancer is a complex 
disease and it was related to poor outcome even after treatment.  
 
In this retrospective study, 48 patients with squamous cell carcinoma of tongue were 
identified from record unit. Patient’s data collected since January 1992 until December 
2005, whereby patients were treated either by Oral & Maxillofacial Department, Dental 
Faculty, University Malaya or Department of ENT University Malaya Medical Centre. 
 
Of 48 patients, only 30 patients eligible for the study and the remaining have to be 
excluded due to several reasons. About 43 % of sample was Chinese and followed by 
Indian, Malays and other races. All the lesion were diagnosed as squamous cell 
carcinoma   and  it  was involved age of  16 to 74 with age mean 50. The incidence was 
common in the old patient group ( >46 ) which recorded 63.3% and 36.7% in young 
patient ( < 46 ).  Gender   ratio almost equal.  
 
80% of cases were diagnosed as oral tongue cancer and the rest involved base of tongue. 
43.3% of patients in stage IV, 30% in stage II and 13.3% in stage I and III. Neck 
involvement; 53.3% with NO , 13.3% with N1, N2a and N2b another 3.3% with N2c 
and N3. Histological grading ;  56.7 % moderately differentiated, 40% well and another 
3.3% poorly differentiated. 
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For the oral tongue, all the cancers were located at lateral border of tongue except one 
occurred on dorsum. Presently, surgery, radiotherapy, chemotherapy or combinations 
are the option treatment modalities for cancer. Patients came to the centre with multi 
characteristics tumour appearances which determined the mode of treatment. 40% 
(n=12) and 27% (n=8) of patients underwent surgery and radiotherapy respectively, 
26.7% received surgery and post operative radiotherapy, 3.3% had radiotherapy and 
surgery and 3.3% had other mode of treatment. Neck treatment; 56.7% do not have any 
neck treatment, 16.7% had radical neck dissection (RND), 16.7% had bilateral neck 
dissections and 10% had selective neck dissection. 
 
Overall 5 year survival was about   27 %. By site, 5 year survival for oral tongue cancer 
was 33% and nil for base of tongue. The 5 years   survival probability for stage I  
(75%),  stage 2 / stage 3 ( 33.3% ) and   7.7% for stage 4. The 5 years survival 
probability for  N0 (43.8%), N2a (25%) and none for N1, N2b, N2c and N3. Staging of 
disease and neck node involvement were statistically significant   for survival. Patient 
with early cancer stage (Stage I & II ) have a better disease control. About 1/3 ( n=11 ) 
of samples have more than 2 years disease free period. Recurrence occurred in 43.3%   
(n=13) of patients and 61.5% of that occurred in the neck region. Out of 30 patients, 
26.7% (n=8) of them still alive and most of them from young group patient (< 46).   
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